Edgar Otto, PhD

Edgar Otto, PhD

University of Michigan

H-index: 80

North America-United States

About Edgar Otto, PhD

Edgar Otto, PhD, With an exceptional h-index of 80 and a recent h-index of 55 (since 2020), a distinguished researcher at University of Michigan, specializes in the field of Nephrology, Human Genetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

WCN24-1387 Integration of Single Cell Data from Human and RNA-Seq Analysis from Rat to Identify Surrogate Drugs Mimicking the Effects of Metabolic Bariatric Surgery

Precision Medicine in Nephrology: An Integrative Framework of Multidimensional Data in the Kidney Precision Medicine Project

Plasma Proteins associated with Chronic Histopathologic Lesions on Kidney Biopsy

Pax protein depletion in proximal tubules triggers conserved mechanisms of resistance to acute ischemic kidney injury preventing transition to chronic kidney disease

Integrated multiomics implicates dysregulation of ECM and cell adhesion pathways as drivers of severe COVID-associated kidney injury

An atlas of healthy and injured cell states and niches in the human kidney

Defining the molecular correlate of arteriolar hyalinosis in kidney disease progression by integration of single cell transcriptomic analysis and pathology scoring

WCN23-0471 THE ENHANCEMENT OF METALLOTHIONEIN BIND METAL PATHWAY WITH SGLT2 INHIBITORS IN KIDNEY PROXIMAL TUBULES OF ADOLESCENTS WITH TYPE 2 DIABETES USING SINGLE CELL RNA-SEQ DATA

Edgar Otto, PhD Information

University

Position

Associate Research Scientist Internal Medicine-Nephrology

Citations(all)

21720

Citations(since 2020)

7289

Cited By

17254

hIndex(all)

80

hIndex(since 2020)

55

i10Index(all)

141

i10Index(since 2020)

107

Email

University Profile Page

Google Scholar

Edgar Otto, PhD Skills & Research Interests

Nephrology

Human Genetics

Top articles of Edgar Otto, PhD

WCN24-1387 Integration of Single Cell Data from Human and RNA-Seq Analysis from Rat to Identify Surrogate Drugs Mimicking the Effects of Metabolic Bariatric Surgery

Kidney International Reports

2024/4/1

Plasma Proteins associated with Chronic Histopathologic Lesions on Kidney Biopsy

Journal of the American Society of Nephrology

2024/2/6

Pax protein depletion in proximal tubules triggers conserved mechanisms of resistance to acute ischemic kidney injury preventing transition to chronic kidney disease

Kidney International

2024/2/1

Defining the molecular correlate of arteriolar hyalinosis in kidney disease progression by integration of single cell transcriptomic analysis and pathology scoring

medRxiv

2023/6/14

WCN23-0471 THE ENHANCEMENT OF METALLOTHIONEIN BIND METAL PATHWAY WITH SGLT2 INHIBITORS IN KIDNEY PROXIMAL TUBULES OF ADOLESCENTS WITH TYPE 2 DIABETES USING SINGLE CELL RNA-SEQ DATA

Kidney International Reports

2023/3/1

SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes

The Journal of clinical investigation

2023/3/1

Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis

Kidney international

2023/3/1

Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients

The Journal of Clinical Investigation

2023/10/16

Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetes

Kidney International

2023/10/1

Glomerular endothelial cell-podocyte stresses and crosstalk in structurally normal kidney transplants

Kidney international

2022/4/1

Multi-scalar data integration links glomerular angiopoietin-tie signaling pathway activation with progression of diabetic kidney disease

Diabetes

2022/12/1

Urinary Transcriptomics Identified Inflammatory Signals Associated With COVID-19-Related AKI

Journal of the American Society of Nephrology

2022

SGLT2 inhibition mitigates perturbations in nephron segment-specific metabolic transcripts and mTOR pathway activity in kidneys of young persons with type 2 diabetes

MedRxiv

2022/7/24

PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan

NPJ Genomic Medicine

2022/7/1

See List of Professors in Edgar Otto, PhD University(University of Michigan)

Co-Authors

academic-engine